Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs

作者: Sanaa Eissa , Samar K. Kassim , Randa Ali Labib , Inas M. El-Khouly , Taghreed M. Ghaffer

DOI: 10.1002/CNCR.20902

关键词:

摘要: BACKGROUND A new, sensitive, noninvasive method for the detection of urothelial carcinomas urinary bladder would open new possibilities in both diagnosis and followup patients. METHODS This study included 228 patients diagnosed with carcinoma, 68 benign lesions, 44 healthy persons served as control group. All were subjected to: serologic schistosomiasis antibody assay serum, urine cytology, estimation hyaluronic acid (HA) by enzyme-linked immunosorbent assay, CK-20 hyaluronidase (HAase) reverse transcription polymerase chain reaction (RT-PCR) cells from voided urine. RESULTS HA mean rank was higher malignant groups than group (P < 0.0001) significantly related to tumor grade = 0.021). HA best-cutoff, determined using receiver operating characteristic curve discriminate between nonmalignant groups, 58.5 units/mg protein at 85.8% sensitivity 60.7% specificity. HAase RNA showed superior (90.8%) over cytology (68.9%) (78.1%) specificity 93.4%, 98.1% 80.2%, respectively. The reached 94.7% a 91.5% when combined CK-20. 4 investigated markers P <0.05. Whereas only stage 0.05). As schistosomiasis, positivity associated 0.038). CONCLUSIONS HAase is promising test high carcinoma detection. Cancer 2005. © 2005 American Society.

参考文章(25)
Lane Eb, Alexander Cm, Use of keratin antibodies in tumor diagnosis. Seminars in Cancer Biology. ,vol. 1, pp. 165- 179 ,(1990)
Ozkutlu D, Slagel Dd, Savell Vh, Cohen Mb, Teague Mw, Jensen Cs, Raab Ss, Lenel Jc, Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy [corrected]. Modern Pathology. ,vol. 9, pp. 225- 232 ,(1996)
Vinata B. Lokeshwar, Norman L. Block, HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade. Urologic Clinics of North America. ,vol. 27, pp. 53- 61 ,(2000) , 10.1016/S0094-0143(05)70234-2
K Weber, M Osborn, Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology Laboratory Investigation. ,vol. 48, pp. 372- 394 ,(1983)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
A. Schermer, Tung-Tien Sun, D. Cooper, Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Laboratory Investigation. ,vol. 52, pp. 243- 256 ,(1985)
Ami Klein, Ruth Zemer, Victor Buchumensky, Ronen Klaper, Israel Nissenkorn, Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma Cancer. ,vol. 82, pp. 349- 354 ,(1998) , 10.1002/(SICI)1097-0142(19980115)82:2<355::AID-CNCR16>3.0.CO;2-Y
Tony B Csoka, Gregory I Frost, Henry HQ Heng, Stephen W Scherer, Gayatry Mohapatra, Robert Stern, None, The Hyaluronidase Gene HYAL1 Maps to Chromosome 3p21.2–p21.3 in Human and 9F1–F2 in Mouse, a Conserved Candidate Tumor Suppressor Locus ☆ ☆☆ Genomics. ,vol. 48, pp. 63- 70 ,(1998) , 10.1006/GENO.1997.5158
VINATA B. LOKESHWAR, MARK S. SOLOWAY, CURRENT BLADDER TUMOR TESTS: DOES THEIR PROJECTED UTILITY FULFILL CLINICAL NECESSITY? The Journal of Urology. ,vol. 165, pp. 1067- 1077 ,(2001) , 10.1016/S0022-5347(05)66428-2
D. Rotem, A. Cassel, N. Lindenfeld, Y. Mecz, Y. Sova, M. Resnick, A. Stein, Urinary cytokeratin 20 as a marker for transitional cell carcinoma. European Urology. ,vol. 37, pp. 601- 604 ,(2000) , 10.1159/000020199